Koninklijke Philips N.V.
NYSE:PHGMedical - Devices
+$0.57 today
- Market cap
- $29.11B
- Beta
- 0.93
- P/E (TTM)
- 23.1
- EPS (TTM)
- $1.02
- Dividend yield
- 3.62%
Volume 1.45M
Average 1.17M
PHG Debt Repayment
Cash used to repay borrowings during the period.
Koninklijke Philips N.V.NYSE: PHG
Debt Repayment · Q2 FY2026 · quarter ended Jun 2026
Debt repayment turns negative
Q2 FY2026 debt repayment was -€767M, compared with €840M a year earlier. Trailing-twelve-month debt repayment was -€1.13B. Over 3 fiscal years it compounded at -26.9% a year.
Context
- Debt repayment amounted to 2.5% of revenue in FY2025, up 2.0 pp from a year earlier.
- Debt repayment increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly debt repayment holds near -€767M or moves back toward the trailing-twelve-month quarterly average of -€282.89M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Debt Repayment history
EUR · from the cash flow
- Latest · FY2025
- 448M EUR
- Year-over-year change
- +605.1%
| Period | Period end | Debt Repayment | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 448M | +605.1% |
| FY2024 | 2024-12-31 | (88.7M) | +54.7% |
| FY2023 | 2023-12-31 | (195.68M) | -117.0% |
| FY2022 | 2022-12-31 | 1.15B | +487.2% |
| FY2021 | 2021-12-31 | (296.68M) | — |
Debt Repayment vs competitors
How PHG compares with its peers on the latest reported figures
- Peers report in different currencies, so debt repayment is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -243.1% is the lowest of 8, against a peer median of -27.6%.
- Debt repayment amounts to 6.4% of revenue for PHG, versus a peer median of 0.6%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $16.44B USD | +1114.1% | +32.2% | 35.3% | |
| LTM Jun 2026 | €1.13B EUR | -243.1% | -26.9% | 6.4% | |
| LTM Jun 2026 | $979M USD | +579.9% | +43.8% | 4.7% | |
| LTM Sep 2026 | $160.05M USD | -27.6% | — | 10.6% | |
| LTM Jul 2026 | $151M USD | +115.7% | +25.2% | 0.4% | |
| FY2025 | $140M USD | -114.8% | +48.2% | 2.3% | |
| LTM Jun 2026 | $118M USD | -112.2% | -51.0% | 0.6% | |
| LTM Jun 2026 | $15M USD | -62.5% | — | 0.3% | |
| LTM Mar 2026 | $133K USD | — | — | 0.1% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding PHG) | — | -27.6% | +32.2% | 0.6% | |
Competitors are the stored peer set for PHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 718.64M | (1.7B) | (492.99M) | (912.95M) | 895M |
| Depreciation & Amortization | 1.32B | 1.6B | 1.26B | 1.39B | 1.13B |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 141M |
| Change in Working Capital | (179.66M) | (1.24B) | 1.51B | 7.57M | (1.33B) |
| Accounts Receivables | 0 | (359.43M) | 322.17M | (1.08M) | (9M) |
| Inventory | (686.73M) | (601.16M) | 277.85M | 248.79M | (115M) |
| Accounts Payables | 258.85M | 54.65M | 387.04M | (630.63M) | 0 |
| Other Working Capital | 248.22M | (337.36M) | 518.94M | 390.49M | (1.21B) |
| Other Non-Cash Items | 64.65M | 1.16B | 35.26M | 1.21B | 330M |
| Operating Cash Flow | 1.93B | (181.82M) | 2.31B | 1.7B | 1.16B |
| Capital Expenditures | (469.25M) | (466.63M) | (371.9M) | (342.9M) | (269M) |
| Acquisitions (Net) | (3.5B) | (600.11M) | 104.87M | 141.7M | (3M) |
| Purchases of Investments | (146.57M) | (197.58M) | (149.19M) | (133.05M) | 0 |
| Sales of Investments | 203.3M | 81.98M | 51.89M | 61.66M | 0 |
| Other Investing Activities | 4.02B | (12.61M) | 134.06M | 27.04M | (465M) |
| Investing Cash Flow | (317.95M) | (1.58B) | (553.53M) | (633.87M) | (737M) |
| Debt Repayment | (296.68M) | 1.15B | (195.68M) | (88.7M) | 448M |
| Common Stock Issued | 27.19M | 12.61M | 0 | 0 | 0 |
| Common Stock Repurchased | (1.93B) | (196.53M) | (715.7M) | (444.57M) | 0 |
| Dividends Paid | (569.71M) | (433M) | (2.16M) | (1.08M) | (328M) |
| Other Financing Activities | (2.36M) | (6.31M) | (3.24M) | (2.16M) | (13M) |
| Financing Cash Flow | (2.77B) | 525.49M | (916.79M) | (536.52M) | 107M |
| Effect of Forex Changes | (162.77M) | (136.41M) | (25.17M) | (105.14M) | (139M) |
| Net Change in Cash | (1.33B) | (1.37B) | 813.77M | 421.64M | 393M |
| Free Cash Flow | 1.46B | (648.45M) | 1.94B | 1.35B | 893M |
Koninklijke Philips N.V.
NYSE:PHG
Intrinsic Alpha fair value
Locked
Current Price
$29.81
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.